Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|December 1, 1994
Lipopolysaccharide and splenic tumoricidal macrophage activationS Verstovsek, G Zaleskis, D L Maccubbin, et al.
Hematology/Oncology Clinics of North America|March 18, 1999
The role of macrophages in antitumor defense of patients with ovarian cancerE Zavadova, A Loercher, S Verstovsek, et al.
Leukemia Research|November 11, 2006
'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical courseC Vaklavas, A Tefferi, J Butterfield, et al.
Experimental Hematology|June 1, 1995
Murine splenic macrophage tumoricidal activation by cytokinesS Verstovsek, C Eppolito, P Ujhazy, et al.
Leukemia & Lymphoma|November 9, 2001
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndromeS Verstovsek, E Estey, T Manshouri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cellsB Scappini, F Onida, H M Kantarjian, et al.
International Journal of Cancer|June 22, 2000
Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 miceM J Ehrke, S Verstovsek, D L Maccubbin, et al.
British Journal of Haematology|September 1, 2001
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndromeS Verstovsek, H Kantarjian, A Aguayo, et al.
Leukemia Research|April 30, 2015
Limitations of fibrosis grade as diagnostic criteria for post polycythemia vera and essential thrombocytosis myelofibrosisK Gowin, S Verstovsek, N Daver, et al.
International Journal of Cancer|November 3, 1995
Cyclophosphamide plus tumor necrosis factor-alpha chemoimmunotherapy cured mice: life-long immunity and rejection of re-implanted primary lymphomaM J Ehrke, S Verstovsek, C M Krawczyk, et al.
Pageof 5